7498 Results (Page 16 of 300)
Pharmaceuticals Markets Research Reports
Spain Gram-Negative Infection Therapeutics Market Analysis
The Spain Gram-Negative Infection Therapeutics Market was valued at $287.1 Mn in 2023 and is predicted to grow at a CAGR of 4.9% from 2023 to 2030 to $401.3 Mn by 2030. Factors fuelling this market expansion include the aging population, heightened research and development efforts, and the increasing prevalence of gram-negative infections. Leading companies in this market include Sanofi, Novartis, Baxter, Takeda, and others.
Germany Gram-Negative Infection Therapeutics Market Analysis
The Germany Gram-Negative Infection Therapeutics Market was valued at $544.4 Mn in 2023 and is predicted to grow at a CAGR of 4.1% from 2023 to 2030 to $721.3 Mn by 2030. Key market growth drivers include increasing prevalence, technological advancements, and growing awareness of antimicrobial resistance (AMR). Major players in this market include Pfizer Inc., Nektar Therapeutics, and other notable companies.
France Gram-Negative Infection Therapeutics Market Analysis
The France Gram-Negative Infection Therapeutics Market was valued at $409.1 Mn in 2023 and is predicted to grow at a CAGR of 4.9% from 2023 to 2030 to $571.8 Mn by 2030. This growth is fuelled by the rising prevalence of healthcare-associated infections (HAIs), affecting approximately 750,000 patients yearly, with a notable portion attributed to gram-negative bacteria. Key players in this market include Pfizer, Sanofi, Baxter, Takeda and others.
Mexico Gram-Negative Infection Therapeutics Market Analysis
The Mexico Gram-Negative Infection Therapeutics Market was valued at $223.1 Mn in 2023 and is predicted to grow at a CAGR of 6.15% from 2023 to 2030 to $338.8 Mn by 2030. This growth is driven by increasing prevalence, growing awareness, and rising investment in R&D. Major players in this market include Baxter and GlaxoSmithKline plc (GSK), among others.
Brazil Gram-Negative Infection Therapeutics Market Analysis
The Brazil Gram-Negative Infection Therapeutics Market was valued at $371.9 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030 to $593.29 Mn by 2030. Key market growth drivers include the increasing prevalence of gram-negative infections, rising antibiotic resistance, and technological advancements. Major players in this market include Nektar Therapeutics, Novartis, and other notable companies.
UAE Gram-Negative Infection Therapeutics Market Analysis
The UAE Gram-Negative Infection Therapeutics Market was valued at $74.4 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030 to $118.7 Mn by 2030. This growth is driven by increasing prevalence, with a rate of approximately 9.8% in healthcare settings. Major players in this market include AbbVie Inc. and Bayer AG, among others.
Saudi Arabia Gram-Negative Infection Therapeutics Market Analysis
The Saudi Arabia Gram-Negative Infection Therapeutics Market was valued at $0.25 Bn in 2023 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030 to $0.42 Bn by 2030. Factors driving this market growth include increasing prevalence, the threat of nosocomial pneumonia, and an aging population. Prominent companies in this market include Baxter, Novartis, and others.
US Gram-Negative Infection Therapeutics Market Analysis
The US Gram-Negative Infection Therapeutics Market was valued at $6247.5 Mn in 2023 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030 to $8166.1 Mn by 2030. A key factor driving this market growth is decreasing antibiotic resistance trends in gram-negative bacteria, increasing prevalence, and innovative therapeutics. Leading companies in this market include Pfizer Inc. and AbbVie Inc. (Allergan Pharmaceuticals Private Limited), among others.
Canada Gram-Negative Infection Therapeutics Market Analysis
The Canada Gram-Negative Infection Therapeutics Market was valued at $1190.08 Mn in 2023 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030 to $1777.5 Mn by 2030. Market dynamics are driven by the increasing incidence of infections, unmet medical needs, and favourable government initiatives. Leading companies in this market include AstraZeneca and Johnson & Johnson, among others.
India Home Infusion Therapy Market
The India Home Infusion Therapy Market was valued at $654 Mn in 2023 and is predicted to grow at a CAGR of 11.1% from 2023 to 2030, to $1366.3 Mn by 2030. The key drivers of the market include low cost, rising prevalence of chronic diseases, and expanding geriatric population. The prominent players of the India Home Infusion Therapy Market are Poly Medicure, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
South Africa Home Infusion Therapy Market
The South Africa Home Infusion Therapy Market was valued at $233.7 Mn in 2023 and is predicted to grow at a CAGR of 9.33% from 2023 to 2030, to $436.4 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the South Africa Home Infusion Therapy Market are SA Homecare, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Kenya Home Infusion Therapy Market
The Kenya Home Infusion Therapy Market was valued at $25.2 Mn in 2023 and is predicted to grow at a CAGR of 9.2% from 2023 to 2030, to $46.6 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, the expanding geriatric population, and technological advancements. The prominent players of the Kenya Home Infusion Therapy Market are Poly Medicure, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Egypt Home Infusion Therapy Market
The Egypt Home Infusion Therapy Market was valued at $100.7 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $191.3 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Egypt Home Infusion Therapy Market are SA Homecare, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Vietnam Home Infusion Therapy Market
The Vietnam Home Infusion Therapy Market was valued at $179.8 Mn in 2023 and is predicted to grow at a CAGR of 8.33% from 2023 to 2030, to $314.8 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Vietnam Home Infusion Therapy Market are QMed Asia, Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Singapore Home Infusion Therapy Market
The Singapore Home Infusion Therapy Market was valued at $43.2 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $77.4 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Singapore Home Infusion Therapy Market are Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Philippines Home Infusion Therapy Market
The Philippines Home Infusion Therapy Market was valued at $79.1 Mn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $140.9 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Philippines Home Infusion Therapy Market are Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Malaysia Home Infusion Therapy Market
The Malaysia Home Infusion Therapy Market was valued at $57.8 Mn in 2023 and is predicted to grow at a CAGR of 8.3% from 2023 to 2030, to $101 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Malaysia Home Infusion Therapy Market are QMed Asia, Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Japan Home Infusion Therapy Market
The Japan Home Infusion Therapy Market was valued at $2235.2 Mn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $3982.3 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Japan Home Infusion Therapy Market are Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Indonesia Home Infusion Therapy Market
The Indonesia Home Infusion Therapy Market was valued at $215.8 Mn in 2023 and is predicted to grow at a CAGR of 8.1% from 2023 to 2030, to $372.2 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Indonesia Home Infusion Therapy Market are Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
China Home Infusion Therapy Market
The China Home Infusion Therapy Market was valued at $2890.7 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $5491.4 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the China Home Infusion Therapy Market are Poly Medicure, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
UK Home Infusion Therapy Market
The UK Home Infusion Therapy Market was valued at $935 Mn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $1415.1 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the UK Home Infusion Therapy Market are Becton, Dickinson and Company (BD), Baxter International, ICU Medical (Smiths Medical), and Fresenius Kabi, among others.
Spain Home Infusion Therapy Market
The Spain Home Infusion Therapy Market was valued at $694 Mn in 2023 and is predicted to grow at a CAGR of 7.1% from 2023 to 2030, to $1121.8 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Spain Home Infusion Therapy Market are Becton, Dickinson and Company (BD), Baxter International, ICU Medical (Smiths Medical), and Fresenius Kabi, among others.
Germany Home Infusion Therapy Market
The Germany Home Infusion Therapy Market was valued at $1316.1 Mn in 2023 and is predicted to grow at a CAGR of 6.3% from 2023 to 2030, to $2018.5 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Germany Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
France Home Infusion Therapy Market
The France Home Infusion Therapy Market was valued at $988.9 Mn in 2023 and is predicted to grow at a CAGR of 7.1% from 2023 to 2030, to $1598.4 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the France Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Mexico Home Infusion Therapy Market
The Mexico Home Infusion Therapy Market was valued at $539.4 Mn in 2023 and is predicted to grow at a CAGR of 8.35% from 2023 to 2030, to $945.6 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Mexico Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.